STUDY SEARCH RESULTS

1 study found for your search request:  8835-059

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)
Condition: Type 2 diabetes mellitus
Minimum Age: 10 years, Maximum Age: 17 years
Gender: All
Study ID: NCT04029480
Status: Active, not recruiting




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site